QC
ICCC icon

Quadrature Capital’s ImmuCell ICCC Stock Holding History

Quadrature Capital’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
+15,415
New +$136K ﹤0.01% 1411

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Quadrature Capital's ICCC Position: Q2 2026 in Review

Quadrature Capital opened a new position in ImmuCell (ICCC) in Q2 2026: 15,415 shares worth $155K. The stake represents ﹤0.01% of the portfolio and ranks #1411 among its holdings.

31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Quadrature Capital held 15,415 shares of ImmuCell worth $155K as of Q2 2026.
  • ImmuCell was a new Quadrature Capital position in Q2 2026.
  • ImmuCell made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1411 holding.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.